Male Breast Cancer: Reevaluate Our Opinion.
Journal
Case reports in oncological medicine
ISSN: 2090-6706
Titre abrégé: Case Rep Oncol Med
Pays: United States
ID NLM: 101581035
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
08
2019
accepted:
14
10
2019
entrez:
25
2
2020
pubmed:
25
2
2020
medline:
25
2
2020
Statut:
epublish
Résumé
Male breast cancers (MBCs) are relatively uncommon malignancy with less than 1% incidence. MBC presents at a later age with a more advanced presentation as compared to the female breast cancer. Due to the paucity of the number of cases and trials regarding the MBC, female breast cancer treatment protocols are applied. Mastectomy and hormonal therapy remains the mainstay of treatment. Moreover, the data about prognosis of MBC remains limited.
Identifiants
pubmed: 32089923
doi: 10.1155/2020/6245415
pmc: PMC7026701
doi:
Types de publication
Case Reports
Langues
eng
Pagination
6245415Informations de copyright
Copyright © 2020 Santosh Kale et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Cell Biochem Biophys. 2015 Jun;72(2):333-8
pubmed: 25543329
J Breast Health. 2016 Jan 01;12(1):1-8
pubmed: 28331724
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Breast Cancer (Dove Med Press). 2010 Oct 04;2:45-58
pubmed: 24367166
Med J Islam Repub Iran. 2016 May 15;30:369
pubmed: 27493913
Lancet. 1998 May 16;351(9114):1451-67
pubmed: 9605801
Ann Surg Oncol. 2009 Apr;16(4):972-8
pubmed: 19184227
Lancet. 1992 Jan 4;339(8784):1-15
pubmed: 1345950
Int J Surg Case Rep. 2016;20S:8-11
pubmed: 26994487